Physician profile
Inna Gitelman
NPI 1023232659
$450.66
in general payments reported to CMS, 2019-2025
11 companies · $24.38 in 2025
The $24.38 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $87.30 · 2023: $129 · 2025: $24.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $129.42 | 2023 | Vtama |
| Janssen Biotech, INC. | $103.14 | 2021-2022 | |
| Pfizer INC. | $68.28 | 2021 | |
| Biofrontera INC. | $24.38 | 2025 | Ameluz |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.86 | 2021 | |
| Genzyme Corporation | $20.86 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.60 | 2021 | |
| Amgen INC. | $17.77 | 2021 | |
| Vyne Pharmaceuticals INC. | $15.74 | 2021 | |
| Incyte Corporation | $15.34 | 2022 | |
| Journey Medical Corporation | $15.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Inna Gitelman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.